MTUS Dr Drug L List v. 4 4 Pharmacy cy a and T Ther erapeu - PowerPoint PPT Presentation

May 27, 2023 •175 likes •250 views

MTUS Dr Drug L List v. 4 4 Pharmacy cy a and T Ther erapeu eutics cs C Committee ee M Meeti ting January 23, 2019 Ad Addition o of drugs addressed in the Traumatic Brain I Injury G Guideline New and Revi vised, D Drug

MTUS Dr Drug L List v. 4 4 Pharmacy cy a and T Ther erapeu eutics cs C Committee ee M Meeti ting January 23, 2019
Ad Addition o of drugs addressed in the Traumatic Brain I Injury G Guideline
New and Revi vised, D Drug Recommendations related to the T Traumatic Brain I Injury G Guideline ne
Des esignatio ion o of addit itio ional d l drugs a as “specia cial f l fill” ll” eligible, d due t to t treatment r recommendation i in the Trau aumatic Brain I Injury G y Guideline

Recommend

Division of Workers Compensation MTUS Formulary Pharmacy and Therapeutics Committee

Division of Workers Compensation MTUS Formulary Pharmacy and Therapeutics Committee Discussion of MTUS Drug L List Structure and Content: Unique Pharmaceutical Id Identifiers Kevin Gorospe, PharmD, DWC Consultant September 26, 2018 MTUS

238 views • 8 slides

MTUS Formulary The initial MTUS Formulary provided for a list of drug ingredients (generic

MTUS Formulary The initial MTUS Formulary provided for a list of drug ingredients (generic drug names) and their indicated uses Some stakeholders requested more specificity, suggesting the use of National Drug Codes (NDCs) for the listed

203 views • 8 slides

MTUS Formulary ry Overv rview Pharmacy and Therapeutics Committee Meeting September 26, 2018

Division of Workers Compensation MTUS Formulary ry Overv rview Pharmacy and Therapeutics Committee Meeting September 26, 2018 Structure of the MTUS Drug Formulary and Role of the ACOEM Treatment Guidelines ACOEM Treatment Guidelines

281 views • 12 slides

REMS and Pharmacy pharmacist to every patient receiving the drug. pharmacist COMMUNICATION PLAN

REMS Elements & Pharmacy MEDICATION GUIDE Document written for patients highlighting important safety information about the drug; this document must be distributed by the REMS and Pharmacy pharmacist to every patient receiving the drug.

343 views • 5 slides

for Drug Savings The Role of Pharmacy Benefit Managers in the Health Care System April

Finding the Formula for Drug Savings The Role of Pharmacy Benefit Managers in the Health Care System April Alexander, PCMA New Hampshire Drug Price Transparency Commission Sept. 18, 2018 What Is a PBM? A pharmacy benefits manager (PBM)

862 views • 26 slides

Pharmacy Regulation Donald H. Williams, RPh, FASHP Affiliate Professor, UW School of Pharmacy

Pharmacy Regulation Donald H. Williams, RPh, FASHP Affiliate Professor, UW School of Pharmacy Objectives Describe Pharmacy regulation process Describe who may prescribe drugs in WA Describe Drug Classifications Describe Drug/Pharmacy

656 views • 34 slides

Evaluation of Drug-Drug Interactions and Their Influence on Drug Dosing in the Pediatric

Evaluation of Drug-Drug Interactions and Their Influence on Drug Dosing in the Pediatric Population Daniel Gonzalez, Pharm.D., Ph.D. Associate Professor Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy

578 views • 57 slides

Applying Pharmacy Scientific Principles to the Laws Associated with Synthetic Drug of Abuse O N

Applying Pharmacy Scientific Principles to the Laws Associated with Synthetic Drug of Abuse O N O N N N H 3 C Jon E. Sprague, RPh, PhD What is a pharmacophore? the portion of drug molecule required for pharmacological activity O O O

627 views • 48 slides

Pharmacy Business Transformation Health Solutions Pharmacy Business Transformation Overview

Pharmacy Business Transformation Health Solutions Pharmacy Business Transformation Overview Expertise in leveraging pharmacy as a strategy for your organizations clinical and financial success Inpatient Expense 340B Audit, Compliance & Drug

612 views • 9 slides

The Pharmacy Technicians Role in Preventing Harmful Drug Interactions Kylie Hutchison,

9/23/2018 The Pharmacy Technicians Role in Preventing Harmful Drug Interactions Kylie Hutchison, PharmD; Leighton Murri, PharmD PGY1 Pharmacy Residents St. Lukes Medical Center Meridian/Boise September 29, 2018 Disclosures We

375 views • 9 slides

MassHealth Pharmacy Program Status Medicaid Prescription Drug Quality and Cost Management

MassHealth Pharmacy Program Status Medicaid Prescription Drug Quality and Cost Management November 13, 2009 Paul L. Jeffrey, Pharm.D. MassHealth Director of Pharmacy 1 MassHealth Overview (FY10) Members 1.23M Members ( 3.4%> FY09)

235 views • 10 slides

Your 2018 Pharmacy Plan Changes 1 New Prescription Drug Program Effective January 1, 2018 Fort

Your 2018 Pharmacy Plan Changes 1 New Prescription Drug Program Effective January 1, 2018 Fort Bend ISD is pleased to announce that effective January 1, 2018, your pharmacy benefit services will be provided by Express Scripts administered

253 views • 10 slides

Drug Enforcement Administration Diversion Investigators Angela Lee Rita Esquivel DEA Pharmacy

Drug Enforcement Administration Diversion Investigators Angela Lee Rita Esquivel DEA Pharmacy Registration Requirements Valid Louisiana State Pharmacy Permit Adherence to all State & Federal Laws Adherence to Louisiana Board of

515 views • 10 slides

A Year in Review: Novel Drug Approvals Robin Parker, PharmD Assistant Professor of Pharmacy

A Year in Review: Novel Drug Approvals Robin Parker, PharmD Assistant Professor of Pharmacy Practice Lipscomb University College of Pharmacy robin.parker@lipscomb.edu Objectives 1. Identify the clinical indications for new FDA approved

698 views • 43 slides

Medicare Part D- What you need to know to save $ on your drug costs Rajul A. Patel, Pharm.D,

Medicare Part D- What you need to know to save $ on your drug costs Rajul A. Patel, Pharm.D, Ph.D. Professor- Pharmacy Practice University of the Pacific Thomas J. Long School of Pharmacy & Health Sciences September 20 th , 2019 Agenda

776 views • 36 slides

How to Use the Prescription Drug Monitoring Program Henrique Pedro, RPh, Lifespan Pharmacy

How to Use the Prescription Drug Monitoring Program Henrique Pedro, RPh, Lifespan Pharmacy Disclosures and Slide/Content Credits No Disclosures to Report This talk represents my individual opinions and does not necessarily represent the

614 views • 14 slides

NATURAL DRUG RESEARCH, PHYTOMEDICINE AND BIOTECHNOLOGY | PHARMACOLOGY, CLINICAL RESEARCH, PHARMACY

Innopharm 2 Oral Presentation Schedule for Day 1 (11 th February 2017) NATURAL DRUG RESEARCH, PHYTOMEDICINE AND BIOTECHNOLOGY | PHARMACOLOGY, CLINICAL RESEARCH, PHARMACY PRACTICE AND PHARMACOVIGILANCE Day 1 Date: 11 Feb 17 Time: 1:30 PM to

376 views • 6 slides

Board of Pharmacy Update Allison Vordenbaumen Benz, R.Ph., M.S. Executive Director Texas

Board of Pharmacy Update Allison Vordenbaumen Benz, R.Ph., M.S. Executive Director Texas Federation of Drug Stores Meeting October 16, 2019 Goals H.B. 3284 PMP Advisory Committee H.B. 2174 E-prescribing H.B. 2088 Drug

407 views • 39 slides

A PRESCRIPTION FOR THE DRUG PRICE EPIDEMIC Derek Oestreicher, Attorney Office of the Montana

A PRESCRIPTION FOR THE DRUG PRICE EPIDEMIC Derek Oestreicher, Attorney Office of the Montana State Auditor, Commissioner of Securities and Insurance Pharmacy Supply Chain Pharmacy Dru rug Dis istrib ibutio ion PBM Regulation Roadblocks

369 views • 7 slides

HCA Drug Spend and Utilization Medicaid and Uniform Medical Plan Prescription Drug Price and

HCA Drug Spend and Utilization Medicaid and Uniform Medical Plan Prescription Drug Price and Purchasing Summit Part 1 June 14, 2016 Donna L. Sullivan, PharmD, MS Chief Pharmacy Officer Total Drug Spend CY 2015 Medicaid FFS a $155,684,155

324 views • 7 slides

MTU Press Conference Engines of the future MTUs contribution to meeting tomorrows

MTU Press Conference Engines of the future MTUs contribution to meeting tomorrows market requirements Reiner Winkler, CEO Michael Schreygg, Chief Program Officer Berlin, May 21, 2014 Commercial aviation is a global Multi

336 views • 15 slides

Impending Inventory Impact: Your pharmacy and requirements under the Drug Supply Chain Security

10/18/19 1 Impending Inventory Impact: Your pharmacy and requirements under the Drug Supply Chain Security Act NCPA Annual Convention 2019 Kala Shankle, J.D. Lisa Schwartz, Pharm.D. NCPA 2 1 10/18/19 Disclosure There are no relevant

267 views • 16 slides

from semisolid dosage forms and its regulatory applications Flavian tefan Rdulescu , Dalia

In vitro drug release from semisolid dosage forms and its regulatory applications Flavian tefan Rdulescu , Dalia Simona Miron University of Medicine and Pharmacy Carol Davila, Bucharest, Faculty Of Pharmacy, Biopharmaceutics Dept. Drug

245 views • 20 slides

New Drug Update Alex Ganetsky, PharmD, BCOP Hematology/Oncology Clinical Pharmacy Specialist

1/27/2015 New Drug Update Alex Ganetsky, PharmD, BCOP Hematology/Oncology Clinical Pharmacy Specialist Hospital of the University of Pennsylvania Disclosure I have no potential or actual conflicts of interest Objectives Describe the

752 views • 15 slides